Clinical Trial Update: A Study on the Effect of Etavopivat on Heart Rhythm in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 study of etavopivat assessing heart rhythm in healthy participants has completed; the trial also lists sickle cell disease and thalassemia as conditions…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Thalassemia

Drugs mentioned

• Etavopivat (Etavopivat)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Healthy Volunteers, Sickle Cell Disease | Phase 1 | Status: COMPLETED